Department of Senological, Gynecological, Plastic and Reconstructive Surgery - Paris Professor Fabrice Lecuru - Institut Curie
  • Endometrial cancer - Ongoing trials

    Ongoing trials

    Participation in therapeutic trials (“research protocols”) allows patients to benefit from therapeutic innovations currently being validated. These studies are subject to multiple validations guaranteeing their scientific interest and respect for ethics, before being offered to patients.

    The main open drug trials are:

    - ROCSAN: addition of immunotherapy and a PARP inhibitor for the treatment of recurrent carcinosarcoma,
    - UTOLA: use of olaparib in endometrial cancer recurrences